Octanine (Human Coagulation Factor Ix)

Human Coagulation Factor IX, the active ingredient in Octanine, is a coagulation factor replacement presented as a sterile solution for intravenous use. It replaces deficient factor IX, restoring activity of the intrinsic pathway of the coagulation cascade in patients with hemophilia B or acquired factor IX deficiency.

GNH USA supplies Octanine as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and clinics worldwide.

Octanine acts on the intrinsic coagulation pathway to replace deficient factor IX in patients with specific bleeding disorders. - Hemophilia B (Factor IX deficiency): provides replacement therapy to prevent or control bleeding episodes. - Acquired factor IX deficiency: restores factor IX activity to manage bleeding. - Perioperative management in factor IX deficiency: supplies hemostatic coverage during surgical procedures.

Octanine may cause a range of adverse reactions following intravenous infusion.

Common Side Effects: - Infusion‑related reactions such as fever, chills, or headache. - Nausea or mild hypotension. - Localized pain at the injection site. - Transient elevated liver enzymes.

Serious or Rare Side Effects: - Anaphylaxis or severe hypersensitivity reactions. - Development of neutralizing inhibitors (antibodies) against factor IX. - Thrombotic events including deep‑vein thrombosis or pulmonary embolism. - Disseminated intravascular coagulation (DIC). - Severe hypertension or hemolysis.

When using Octanine, several precautions should be observed to ensure safe and effective therapy. - Dose individualization: adjust dosing based on factor IX activity levels and clinical response. - Bleeding monitoring: regularly assess for signs of bleeding or inadequate hemostasis. - Inhibitor surveillance: test periodically for development of anti‑factor IX antibodies. - Pregnancy considerations: use only if the benefit outweighs potential risk to the fetus. - Store at 2‑8°C: keep refrigerated, protect from light, do not freeze or shake.

Octanine can interact with other medications that affect coagulation or immune response.

Major Interactions (Avoid): - Antifibrinolytics (e.g., tranexamic acid): may increase thrombosis risk when combined with high factor IX levels. - Procoagulant agents (e.g., activated factor VII): can cause excessive clot formation. - Live attenuated vaccines: potential alteration of immune response.

Moderate Interactions (Monitor Closely): - Heparin: may potentiate anticoagulant effect; monitor coagulation parameters. - Warfarin: may affect overall coagulation balance; monitor INR. - Immunosuppressants: could influence inhibitor development; observe clinical response.